The Procter & Gamble Company
PG
$158.06
-$0.5901-0.37%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 19.78B | 21.88B | 21.74B | 20.53B | 20.20B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 19.78B | 21.88B | 21.74B | 20.53B | 20.20B |
Cost of Revenue | 9.67B | 10.39B | 10.38B | 10.25B | 9.86B |
Gross Profit | 10.11B | 11.49B | 11.36B | 10.28B | 10.34B |
SG&A Expenses | 5.50B | 5.54B | 5.32B | 5.89B | 5.88B |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 15.17B | 15.93B | 15.70B | 16.14B | 15.74B |
Operating Income | 4.61B | 5.95B | 6.04B | 4.39B | 4.46B |
Income Before Tax | 4.66B | 5.85B | 5.14B | 3.87B | 4.59B |
Income Tax Expenses | 868.00M | 1.19B | 1.15B | 726.00M | 812.00M |
Earnings from Continuing Operations | 3.79B | 4.66B | 3.99B | 3.14B | 3.78B |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -23.00M | -29.00M | -28.00M | -7.00M | -27.00M |
Net Income | 3.77B | 4.63B | 3.96B | 3.14B | 3.75B |
EBIT | 4.61B | 5.95B | 6.04B | 4.39B | 4.46B |
EBITDA | 5.30B | 6.65B | 6.76B | 5.15B | 5.17B |
EPS Basic | 1.58 | 1.94 | 1.65 | 1.27 | 1.56 |
Normalized Basic EPS | 1.25 | 1.55 | 1.59 | 1.11 | 1.20 |
EPS Diluted | 1.54 | 1.88 | 1.61 | 1.27 | 1.52 |
Normalized Diluted EPS | 1.19 | 1.49 | 1.52 | 1.08 | 1.15 |
Average Basic Shares Outstanding | 2.35B | 2.35B | 2.36B | 2.41B | 2.36B |
Average Diluted Shares Outstanding | 2.45B | 2.46B | 2.47B | 2.47B | 2.47B |
Dividend Per Share | 1.01 | 1.01 | 1.01 | 1.01 | 0.94 |
Payout Ratio | 64.55% | 52.72% | 61.76% | 78.07% | 60.87% |